Research Management and Impact Tool (ReMIT)

Survey of Plasmodium falciparum Sulfadoxine/pyrimethamine (SP) resistance markers in MSF projects in North and South Kivu, DRC

Principal investigator

Location

Congo (Democratic Republic of the)
Topics

Malaria, Other
Methodology

Observational study
Reference

OCA017-05
Views

161
Downloaded

3

Purpose of study

Purpose of study

To measure the prevalence of molecular markers of SP resistant malaria in North and South Kivu, DRC.

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

CP_protocol_FINAL_with_LSTMH_approval.docx 679 KB
CP_protocol_FINAL_with_LSTMH_approval.docx 679 KB
Ethics_approval_LSTMH.pdf 273 KB
Appendix_Participant_Information_and_Consent_Sheet_SP_FINAL_with_LSTMH_approval.docx 33.7 KB
MSF_Research_Ethics_Template_SP_resistance_v2_submitted.docx 36.1 KB
1708_Pre-ethics_review_20_February_2017.pdf 549 KB
Reply_to_MSF_ERB_SP_protocol_DRC_1708.docx 24 KB
Annex_2_Participant_Information_and_Consent_Sheet_SP_FINAL_after_MSF_ERB.docx 33.8 KB
SP_protocol__MSF_ERB.docx 684 KB
Annex_5_Timeline_SP_study.xlsx 9.73 KB
Annex_6_Budget_SP_study_estimation.xls 35 KB
1708_MSF_ERB_Review_05_May_2017.pdf 422 KB
SP_protocol_MSF_ERB_changes_accepted_final_MSF_ERB_07_06.docx 760 KB
Annex_3_Participant_Information_and_Consent_Sheet_SP_for_minors_0706.docx 36.7 KB
Reply_to_1708_MSF_ERB_Review_05_May_2017.docx 43.8 KB
1708_MSF_ERB_Approval_12_June_2017.pdf 99.5 KB
Annex_1_MTA_Radboudumc_SP_study_DRC.v2.doc 132 KB
Annex_4_Pictorial_explanation_SP_study_and_malaria_treatment.docx 524 KB

Publications

Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention

van Lenthe, Marit "–" Springer Science and Business Media LLC "(2019)"

Previous study

Next study